Skip to main content
Caplight Logo









Leucine Rich Bio

Leucine Rich Bio

Private
Bangalore, KarnatakaHealthcare & Life Scienceshttps://leucinerichbio.com/

Last Round

Pre Seed

Oct 19, 2023

Total Funding Raised

$360,700

Company Overview

Leucine Rich Bio is a biotechnology company that has developed a genomics-based platform to analyze microbiomes, offering personalized nutritional recommendations and supplements.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, D2C Brands, Healthcare Analytics

Business Model

B2C

Customer Profile

Hardware Sales, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

gut microbiome testmicrobiome testingpersonalized nutritiongut healthmicrobiome analysisprobiotic supplementsprecision medicinegut testpreventive healthcareat-home test kitnext-generation sequencingNGSpersonalized probioticsD2C healthsynbiotic supplementsmicrobiome research servicesFaecal Microbiota TransplantFMT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Leucine Rich Bio Comparables

Compare Leucine Rich Bio with similar companies based on industry and business-model similarity.

Leucine Rich Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mapmygenome
86%
Sova Health
84%
Microbiome Research
82%

Leucine Rich Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedOct 19, 2023
GrantJan 15, 2022
AcceleratorMay 17, 2021

Key People

Founding team and executive leadership

Prabhath K. M.

Co-Founder and CPO

Founding Team

Kumar Sankaran

CEO

Executive Team

Leucine Rich Bio Investors

Notable investors and investment history

Leucine Rich Bio investors
InvestorRounds
MassChallenge IsraelAccelerator
Government of IndiaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 19, 2026

    Grew 24% QoQ, from 29 to 36 employees.

  • Nov 12, 2025

    Grew 16% QoQ, from 25 to 29 employees.

Leucine Rich Bio Filings

Explore SEC and related filing metadata, where available.

Leucine Rich Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Leucine Rich Bio's valuation, stock price, and market status.

Is Leucine Rich Bio a public or private company?

Leucine Rich Bio is a private company.

What is the current stock price of Leucine Rich Bio?

Leucine Rich Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Leucine Rich Bio worth (valuation)?

Valuation information for Leucine Rich Bio is not publicly available.

Can I buy Leucine Rich Bio stock?

Leucine Rich Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Leucine Rich Bio's last funding round?

Leucine Rich Bio's most recent funding round was Pre Seed on October 19, 2023.

Who are the main investors in Leucine Rich Bio?

Key investors in Leucine Rich Bio include MassChallenge, Government of India.

Will Leucine Rich Bio IPO soon?

No public IPO plans have been announced for Leucine Rich Bio.

How can I track Leucine Rich Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Leucine Rich Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBangalore, Karnataka
Employee Range35
Year Founded2014
Last FundingOct 19, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?